Buy AOD9604 2mg
HGH-derived lipolytic fragment for targeted fat loss without anabolic side effects
Verified AOD9604 2mg — AOD9604 is the lipolytic C-terminal fragment of human growth hormone (hGH 177-191) that stimulates fat breakdown and inhibits lipogenesis without growth-promoting side effects.
- Stimulates lipolysis via β3-adrenergic receptor activation
- Inhibits lipogenesis by downregulating fatty acid synthase
- No IGF-1 production or growth-promoting side effects
- No effect on blood glucose or insulin sensitivity
- Targeted fat loss without anabolic risks of full hGH
COA verified · US domestic shipping
AOD9604: The Pure Lipolytic Fragment of Growth Hormone With Clinical Safety Data
Pure Fat Loss Mechanism
AOD9604 contains only the lipolytic domain of hGH — stimulating fat breakdown and inhibiting fat storage without any of the anabolic, growth-promoting, or diabetogenic effects of full hGH.
No IGF-1 Production
Unlike hGH, AOD9604 does not activate IGF-1 signaling — eliminating cancer risk concerns, tissue growth, and glucose intolerance associated with elevated IGF-1.
Clinical Safety Validation
Phase IIb clinical trials established AOD9604's safety profile in humans — providing regulatory-grade evidence that this fragment is well-tolerated at therapeutic doses.
GLP-1 Complement
While GLP-1 agonists suppress appetite to reduce caloric intake, AOD9604 directly accelerates fat mobilization — a complementary mechanism for comprehensive body fat reduction.
The Science Behind AOD9604 2mg
▸The Fat-Burning Fragment of Growth Hormone
AOD9604 is a synthetic peptide comprising amino acids 177–191 of the C-terminus of human growth hormone — the fragment responsible for hGH's lipolytic (fat-breaking) activity. Unlike full-length hGH, AOD9604 does not bind to the IGF-1 receptor, produce IGF-1, promote glucose intolerance, or cause tissue growth — it is purely the fat-mobilizing portion of hGH with none of the anabolic risks.
▸Mechanism: Lipolysis Without IGF-1
AOD9604 mimics the way endogenous growth hormone stimulates fat breakdown: by activating β3-adrenergic receptors in adipose tissue and stimulating hormone-sensitive lipase, which hydrolyzes stored triglycerides into free fatty acids for energy use. It simultaneously inhibits lipogenesis (new fat creation) by downregulating fatty acid synthase activity. The result is a dual action on fat metabolism — more breakdown, less storage.
▸Clinical Background
AOD9604 has progressed through Phase IIb clinical trials for obesity with a good safety profile. While the clinical trials were not powered for approval, the safety data established that AOD9604 does not affect blood glucose, does not cause insulin resistance, and has no significant adverse effects at research doses — addressing key concerns with full hGH use for fat loss.
Complete AOD9604 2mg Benefits
- Stimulates lipolysis via β3-adrenergic receptor activation
- Inhibits lipogenesis by downregulating fatty acid synthase
- No IGF-1 production or growth-promoting side effects
- No effect on blood glucose or insulin sensitivity
- Targeted fat loss without anabolic risks of full hGH
- Phase IIb clinical trial safety data
- Complements appetite-suppressing GLP-1 agents for comprehensive fat loss
AOD9604 2mg Dosing Protocol
Reconstitution: Add 1mL bacteriostatic water (2,000mcg/mL).
Dosing:
• Fat loss: 300–500mcg subcutaneous once daily, preferably fasted morning
• Cycle: 12–16 weeks continuous
• Best combined with caloric deficit and resistance training
Timing: Morning fasted injection maximizes lipolytic effect
All information on this site is for educational purposes only. Always consult with a qualified healthcare provider before use. COA documentation is available for all products.
AOD9604 2mg
COA verified · Third-party tested · US domestic shipping
Buy Now View Stack ProtocolsGLP receptor agonists work via hypothalamic appetite regulation and metabolic enhancement — proven in large-scale clinical trials.
All Weight Loss PeptidesStacks Best With
Stack AOD9604 2mg With
Weight Loss5-Amino-1MQ 50mg
NNMT inhibitor for fat cell reduction, NAD+ elevation, and metabolic enhancement
Buy 5-Amino-1MQ 50mg — 5-Amino-1MQ is a selective NNMT inhibitor that reduces fat cell size, elevates intracellular NAD+, and enhances metabolic rate — the mechanistically novel small molecule for body composition.
Weight LossAOD9604 5mg
Larger supply HGH lipolytic fragment for extended fat loss protocols
Buy AOD9604 5mg — AOD9604 5mg — extended supply of the hGH lipolytic fragment for longer fat loss cycles without mid-protocol reconstitution.
Weight LossAdipotide (FTPP) 5mg
Proapoptotic peptide that destroys adipose blood supply for targeted fat loss
Cheap Adipotide (FTPP) 5mg — Adipotide (FTPP) is a chimeric proapoptotic peptide that selectively destroys the blood vessels supplying white adipose tissue, causing fat cell death through targeted vascular elimination.